Raymond James Financial
RCUS icon

Raymond James Financial’s Arcus Biosciences RCUS Stock Holding History

Raymond James Financial’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.65M Buy
53,680
+15,914
+42% +$393K ﹤0.01% 3633
2026
Q1 		$816K Sell
37,766
-3,058
-7% -$66K ﹤0.01% 3999
2025
Q4 		$973K Buy
40,824
+5,257
+15% +$107K ﹤0.01% 3795
2025
Q3 		$484K Buy
35,567
+181
+0.5% +$1.88K ﹤0.01% 4136
2025
Q2 		$288K Sell
35,386
-497
-1% -$4.25K ﹤0.01% 4310
2025
Q1 		$282K Buy
35,883
+221
+0.6% +$2.56K ﹤0.01% 4253
2024
Q4 		$531K Buy
+35,662
New +$582K ﹤0.01% 3868

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Raymond James Financial's RCUS Position: Q2 2026 in Review

Raymond James Financial increased its Arcus Biosciences (RCUS) stake by 42% in Q2 2026, buying an estimated $393K and bringing the position to 53,680 shares worth $1.65M. The position accounts for ﹤0.01% of the portfolio, ranked #3633.

Raymond James Financial first reported a position in RCUS in Q4 2024 and has held it in 7 quarters since. 231 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Raymond James Financial held 53,680 shares of Arcus Biosciences worth $1.65M as of Q2 2026.
  • Raymond James Financial bought 15,914 Arcus Biosciences shares in Q2 2026, an estimated $393K.
  • Arcus Biosciences made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #3633 holding.
  • Raymond James Financial first reported a position in Arcus Biosciences in Q4 2024 and has held it in 7 quarters since.
  • 231 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.